CORONA, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Watson’s senior management will provide an overview of the Company’s business at the 22nd Annual JPMorgan Healthcare Conference on Thursday, January 15, 2004 at 9:00 a.m. PST.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )
This presentation will be webcast live and can be accessed at Watson Pharmaceuticals’ Web site http://www.watsonpharm.com/ . Click on Investors, and then click on Events. The webcast can also be accessed at the following URL: http://equityconferences.jpmorgan.com/ . An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watsonpharm.com/ .
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.
CONTACT: investors, Patty Eisenhaur, +1-909-493-5611, or media, ChrisEso, +1-909-493-4013, both of Watson Pharmaceuticals, Inc.
Web site: http://equityconferences.jpmorgan.com/
Web site: http://www.watsonpharm.com/
